Hepatic hemangioma pathophysiology: Difference between revisions
Nawal Muazam (talk | contribs) No edit summary |
Nawal Muazam (talk | contribs) No edit summary |
||
Line 9: | Line 9: | ||
===First theory=== | ===First theory=== | ||
*The first theory supports the notion that there is overexpression of angiogenic factors such as:<ref name="PapafragkakisMoehlen2011">{{cite journal|last1=Papafragkakis|first1=Haris|last2=Moehlen|first2=Martin|last3=Garcia-Buitrago|first3=Monica T.|last4=Madrazo|first4=Beatrice|last5=Island|first5=Eddie|last6=Martin|first6=Paul|title=A Case of a Ruptured Sclerosing Liver Hemangioma|journal=International Journal of Hepatology|volume=2011|year=2011|pages=1–5|issn=2090-3456|doi=10.4061/2011/942360}}</ref> | *The first theory supports the notion that there is overexpression of angiogenic factors such as:<ref name="PapafragkakisMoehlen2011">{{cite journal|last1=Papafragkakis|first1=Haris|last2=Moehlen|first2=Martin|last3=Garcia-Buitrago|first3=Monica T.|last4=Madrazo|first4=Beatrice|last5=Island|first5=Eddie|last6=Martin|first6=Paul|title=A Case of a Ruptured Sclerosing Liver Hemangioma|journal=International Journal of Hepatology|volume=2011|year=2011|pages=1–5|issn=2090-3456|doi=10.4061/2011/942360}}</ref> | ||
:*Vascular endothelial growth factor | :*[[Vascular endothelial growth factor]] | ||
:*Basic fibroblast growth factor | :*[[Basic fibroblast growth factor]] | ||
:*Metalloproteinases | :*[[Metalloproteinases]] | ||
*And there is downregulation of some inhibitors of angiogenesis such as:<ref name="PapafragkakisMoehlen2011">{{cite journal|last1=Papafragkakis|first1=Haris|last2=Moehlen|first2=Martin|last3=Garcia-Buitrago|first3=Monica T.|last4=Madrazo|first4=Beatrice|last5=Island|first5=Eddie|last6=Martin|first6=Paul|title=A Case of a Ruptured Sclerosing Liver Hemangioma|journal=International Journal of Hepatology|volume=2011|year=2011|pages=1–5|issn=2090-3456|doi=10.4061/2011/942360}}</ref> | *And there is downregulation of some inhibitors of angiogenesis such as:<ref name="PapafragkakisMoehlen2011">{{cite journal|last1=Papafragkakis|first1=Haris|last2=Moehlen|first2=Martin|last3=Garcia-Buitrago|first3=Monica T.|last4=Madrazo|first4=Beatrice|last5=Island|first5=Eddie|last6=Martin|first6=Paul|title=A Case of a Ruptured Sclerosing Liver Hemangioma|journal=International Journal of Hepatology|volume=2011|year=2011|pages=1–5|issn=2090-3456|doi=10.4061/2011/942360}}</ref> | ||
:*Tissue inhibitor of metalloproteinase-I | :*[[Metalloproteinase|Tissue inhibitor of metalloproteinase-I]] | ||
===Second theory=== | ===Second theory=== | ||
*The second theory is that the presence of liver hemangiomas involves a genetic background of mutations.<ref name="PapafragkakisMoehlen2011">{{cite journal|last1=Papafragkakis|first1=Haris|last2=Moehlen|first2=Martin|last3=Garcia-Buitrago|first3=Monica T.|last4=Madrazo|first4=Beatrice|last5=Island|first5=Eddie|last6=Martin|first6=Paul|title=A Case of a Ruptured Sclerosing Liver Hemangioma|journal=International Journal of Hepatology|volume=2011|year=2011|pages=1–5|issn=2090-3456|doi=10.4061/2011/942360}}</ref> | *The second theory is that the presence of liver hemangiomas involves a genetic background of mutations.<ref name="PapafragkakisMoehlen2011">{{cite journal|last1=Papafragkakis|first1=Haris|last2=Moehlen|first2=Martin|last3=Garcia-Buitrago|first3=Monica T.|last4=Madrazo|first4=Beatrice|last5=Island|first5=Eddie|last6=Martin|first6=Paul|title=A Case of a Ruptured Sclerosing Liver Hemangioma|journal=International Journal of Hepatology|volume=2011|year=2011|pages=1–5|issn=2090-3456|doi=10.4061/2011/942360}}</ref> | ||
*Zhang et al. presumed that metalloproteinases accumulate in the endoplasmic reticulum of the tumor cells causing: | *Zhang et al. presumed that [[metalloproteinases]] accumulate in the endoplasmic reticulum of the tumor cells causing: | ||
:*Self-digestion | :*Self-digestion | ||
:*Vacuole formation | :*Vacuole formation |
Revision as of 19:25, 10 November 2015
Hepatic hemangioma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hepatic hemangioma pathophysiology On the Web |
American Roentgen Ray Society Images of Hepatic hemangioma pathophysiology |
Risk calculators and risk factors for Hepatic hemangioma pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
Development of hepatic hemangioma is the result of genetic mutations, overexpression of angiogenic fators and downregulation of inhibitors of angiogenesis.[1] Hepatic hemangioma may be associated with Kasabach-Merritt syndrome, hereditary hemorrhagic telangiectasia, hepatic arterio-portal shunts, extra hepatic hemangiomata, hemolytic anemia, Focal nodular hyperplasia.[2] On gross pathology, variable in size, well circumscribed, and classically subcapsular are findings of hepatic hemangioma.[3] On microscopic histopathological analysis channels lined by benign endothelium containing RBCs, surrounding (non-endothelial) cells without significant atypia are findings of hepatic hemangioma.[4]
Pathophysiology
Pathogenesis
The pathogenesis of hemangiomas has not been elucidated, but there are two competing theories.
First theory
- The first theory supports the notion that there is overexpression of angiogenic factors such as:[1]
- And there is downregulation of some inhibitors of angiogenesis such as:[1]
Second theory
- The second theory is that the presence of liver hemangiomas involves a genetic background of mutations.[1]
- Zhang et al. presumed that metalloproteinases accumulate in the endoplasmic reticulum of the tumor cells causing:
- Self-digestion
- Vacuole formation
- Additionally, Hu et al. showed the cavernous hemangioma cell to downregulate Derlin-1.
- Derlin-1 is a protein that when overexpressed induces the dilated endoplasmic reticulum to return to its normal size.
Associated Conditions
Hepatic hemangioma may be associated with:[2]
- Kasabach-Merritt syndrome
- Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease)
- Hepatic arterio-portal shunts
- Extra hepatic hemangiomata
- Hemolytic anemia
- Consumptive coagulopathy
- Focal nodular hyperplasia
Gross Pathology
On gross pathology, variable in size, well circumscribed, and classically subcapsular are findings of hepatic hemangioma.[3]
Microscopic Pathology
On microscopic histopathological analysis channels lined by benign endothelium containing RBCs, surrounding (non-endothelial) cells without significant atypia are findings of hepatic hemangioma.[4]
Gallery
-
Intermediate magnification micrograph of a cavernous hemangioma of the liver, also hepatic cavernous hemangioma, liver hemangioma,cavernous liver hemangioma. H&E stain. No liver tissue is observed.[4]
-
High magnification micrograph of a cavernous hemangioma of the liver, also hepatic cavernous hemangioma, liver hemangioma,cavernous liver hemangioma. H&E stain. No liver tissue is observed.[4]
References
- ↑ 1.0 1.1 1.2 1.3 Papafragkakis, Haris; Moehlen, Martin; Garcia-Buitrago, Monica T.; Madrazo, Beatrice; Island, Eddie; Martin, Paul (2011). "A Case of a Ruptured Sclerosing Liver Hemangioma". International Journal of Hepatology. 2011: 1–5. doi:10.4061/2011/942360. ISSN 2090-3456.
- ↑ 2.0 2.1 Associations of hepatic hemangioma. Dr Yuranga Weerakkody et al. Radiopaedia (2015). http://radiopaedia.org/articles/hepatic-haemangioma-3. Accessed on November 7, 2015
- ↑ 3.0 3.1 Gross pathology of hepatic hemangioma. Librepathology 2015. http://librepathology.org/wiki/index.php/Hemangioma_of_the_liver. Accessed on October 20, 2015
- ↑ 4.0 4.1 4.2 4.3 Microscopic features of hepatic hemangioma. Librepathology 2015. http://librepathology.org/wiki/index.php/Hemangioma_of_the_liver. Accessed on October 20, 2015